No more needles? new device aims to make blood tests painless
NCT ID NCT07260799
First seen Jun 24, 2026 · Last updated Jul 21, 2026 · Updated 3 times
Summary
This study tests whether a new device called Tasso+, which collects blood from the skin (like a finger prick), can give the same results as a standard needle draw from a vein. Researchers will compare blood samples from 150 healthy adults and patients with abnormal lab values. If the device works well, it could make blood collection easier and less painful.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Tasso+ Serum Gel Capillary Blood Collection System (a device for collecting blood from the skin)
- What this could lead to
- If successful, this could offer a less painful, more convenient way to collect blood for common lab tests, potentially making testing easier for patients.
- What could go wrong
- This is a small, early-stage study (150 people) comparing capillary to venous blood. It may not prove the device works for all patients or all tests, and results may not apply to other settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Healthy individuals or patients with abnormal analyte values (verified or likely to be) within intended clinical reference ranges as indicated by standard of care testing and/or past medical history.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults aged 18-85 years with no previous experience with the Tasso+ lancet 2. Willing and able to provide written informed consent prior to study entry 3. Willing and able to adhere to study assessments, schedule, prohibitions and restrictions as described in the protocol 4. Healthy individuals or patients with abnormal analyte values (verified or likely to be) within intended clinical reference ranges as indicated by standard of care testing and/or past medical history, in the judgement of the investigator Exclusion Criteria: 1. Present with abnormal skin integrity or atypical skin health near/on arm collection sites 2. Mental or physical impairment which would preclude participation in the judgement of the investigator or qualified designee 3. Trained clinical laboratory and healthcare personnel who have worked in the field in the previous 5 years 4. Any condition which, in the opinion of the investigator or delegate, makes the participant unsuitable for this study (including, but not limited to, any mental or physical impairment which would preclude provision of adequate and knowledgeable consent)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Serum analytes are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Celesta / American Research Labs
Atlantis, Florida, 33462, United States
-
Tasso, Inc.
Seattle, Washington, 98119, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.